FDA Adverse Event
Injury
Summary report: N
FINELINE II
MDR report key: 1771397
·
Received July 27, 2010
Report
- Report Number
- 2124215-2010-12471
- Event Type
- Injury
- Date Received
- July 27, 2010
- Date of Event
- June 10, 2010
- Report Date
- June 11, 2010
- Manufacturer
- CPI - DEL CARIBE
- Product Code
- NVN
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Occupation
- PHYSICIAN
Narratives
Additional Manufacturer Narrative · 1
AT THIS TIME, NO ADDITIONAL INFORMATION HAS BEEN RECEIVED. IF NEW INFORMATION IS FORWARDED, THE EVENT WILL BE REOPENED AND UPDATED.
Description of Event or Problem · 1
BOSTON SCIENTIFIC CRM RECEIVED INFORMATION THAT DURING A ROUTINE CLINICAL FOLLOW-UP, LOSS OF CAPTURE AND UNDERSENSING WERE OBSERVED WITH THIS RIGHT VENTRICULAR LEAD. THE LEAD WAS CONFIRMED DISLODGED AND THE DEVICE REPROGRAMMED TO AAI. NO ADVERSE PATIENT EFFECTS WERE REPORTED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | FINELINE II | IMPLANTABLE LEAD | NVN | CPI - DEL CARIBE | 4457 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 77 YR | Required Intervention | 4480| S602| 4457 |